We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+8.17%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$288M
AUM Growth
-$5.67M
Cap. Flow
-$23.1M
Cap. Flow %
-8.03%
Top 10 Hldgs %
35%
Holding
83
New
8
Increased
26
Reduced
32
Closed
14

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$8.29M
2
WBA
Walgreens Boots Alliance
WBA
+$5.14M
3
STJ
St Jude Medical
STJ
+$3.41M
4
BIIB icon
Biogen
BIIB
+$2.93M
5
CNC icon
Centene
CNC
+$2.84M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$5.52M
2
UNH icon
UnitedHealth
UNH
+$4.73M
3
COR icon
Cencora
COR
+$4.62M
4
CAH icon
Cardinal Health
CAH
+$3.36M
5
MDVN
MEDIVATION, INC.
MDVN
+$3.23M

Sector Composition

Rank Sector Weight
1 Healthcare 83.66%
2 Financials 3.08%
3 Energy 1.06%
4 Industrials 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKRX
51
DELISTED
Akorn Inc
AKRX
$2.18M 0.76%
50,000
+20,000
+67% +$925K
DGX icon
52
Quest Diagnostics
DGX
$26.3B
$2.18M 0.76%
30,000
-40,000
-57% -$2.95M
VRTX icon
53
Vertex Pharmaceuticals
VRTX
$134B
$2.1M 0.73%
+17,000
New +$2.14M
ACAD icon
54
Acadia Pharmaceuticals
ACAD
$5.1B
$2.09M 0.73%
50,000
+15,000
+43% +$581K
HSP
55
DELISTED
HOSPIRA INC
HSP
$2.07M 0.72%
23,300
-3,000
-11% -$264K
HRC
56
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.07M 0.72%
38,020
-10,000
-21% -$519K
GEN
57
DELISTED
Genesis Healthcare, Inc.
GEN
$2.03M 0.7%
307,580
-92,420
-23% -$623K
TRNX
58
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$2M 0.69%
80,000
-50,000
-38% -$1.3M
MOH icon
59
Molina Healthcare
MOH
$10.2B
$1.93M 0.67%
27,500
-22,600
-45% -$1.51M
PTLA
60
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.37M 0.47%
30,000
+5,000
+20% +$201K
ESPR
61
DELISTED
Esperion Therapeutics
ESPR
$1.23M 0.43%
+15,000
New +$1.47M
PTCT icon
62
PTC Therapeutics
PTCT
$6.18B
$1.2M 0.42%
+25,000
New +$1.46M
JUNO
63
DELISTED
Juno Therapeutics, Inc.
JUNO
$1.07M 0.37%
20,000
– –
BLUE
64
DELISTED
bluebird bio
BLUE
$1.01M 0.35%
463
-232
-33% -$473K
ANAC
65
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$1.01M 0.35%
+13,000
New +$852K
CAH icon
66
Cardinal Health
CAH
$55.6B
$962K 0.33%
11,500
-38,000
-77% -$3.36M
COR icon
67
Cencora
COR
$62.8B
$957K 0.33%
9,000
-41,000
-82% -$4.62M
SAGE
68
DELISTED
Sage Therapeutics
SAGE
$949K 0.33%
+13,000
New +$836K
CCRN
69
DELISTED
Cross Country Healthcare
CCRN
$863K 0.3%
68,028
-96,972
-59% -$1.1M
A icon
70
Agilent Technologies
A
$42.3B
– –
-70,000
Closed -$2.91M
ABT icon
71
Abbott
ABT
$189B
– –
-50,000
Closed -$2.32M
ALGN icon
72
Align Technology
ALGN
$12.3B
– –
-35,000
Closed -$1.88M
AMGN icon
73
Amgen
AMGN
$224B
– –
-20,000
Closed -$3.2M
AVNS
74
DELISTED
Avanos Medical
AVNS
– –
-50,000
Closed -$2.46M
IRWD icon
75
Ironwood Pharmaceuticals
IRWD
$696M
– –
-89,550
Closed -$1.2M
1 2
3
4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Sivik Global Healthcare's Q2 2015 Portfolio in Review

As of Q2 2015, Sivik Global Healthcare held 83 positions worth $288M, down 1.9% from $294M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Sivik Global Healthcare withdrew a net $23.1M in Q2 2015, closing 14 positions and reducing 32 holdings. Its most notable exit was UnitedHealth, an estimated $4.73M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in Cigna worth $9.72M.

  • Sivik Global Healthcare's largest Q2 2015 buy was Cigna: 60,000 shares worth $9.72M.
  • Sivik Global Healthcare added most to St Jude Medical in Q2 2015, an estimated $3.41M increase.
  • Sivik Global Healthcare's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $5.52M.
  • Sivik Global Healthcare fully exited UnitedHealth in Q2 2015, selling an estimated $4.73M.
  • Sivik Global Healthcare's ten largest holdings make up 35% of its $288M portfolio in Q2 2015.
  • Sivik Global Healthcare opened 8 new positions and closed 14 in Q2 2015.
  • Sivik Global Healthcare's portfolio value fell 1.9% quarter-over-quarter to $288M.

Based on Sivik Global Healthcare's 13F filing for Q2 2015, filed 6 Jul 2015.